PA
BMY.RT

Parallel Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Parallel Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,867
Closed -$3K – 2981
2020
Q4 		$3K Hold
4,867
– – ﹤0.01% 2251
2020
Q3 		$11K Hold
4,867
– – ﹤0.01% 1718
2020
Q2 		$17K Buy
+4,867
New +$17.6K ﹤0.01% 1493

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Parallel Advisors's BMY.RT Position: Q1 2021 in Review

Parallel Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 4,867 shares — an estimated $3K sold.

Parallel Advisors first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $17K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Parallel Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Parallel Advisors sold 4,867 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $3K.
  • Parallel Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • Parallel Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $17K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Parallel Advisors's 13F filing for Q1 2021, filed 23 Apr 2021.